UPDATE : Monday, October 15, 2018
상단여백
Chong Kun Dang gets license for generic immunosuppressant
Chong Kun Dang said it has obtained approval for Raparobell, a generic copy...
by So Jae-hyeon  |  2018-08-03 15:38
라인
GC Labcell, AbClon to develop CAR-NK cell treatment
GC Labcell CEO Park Dae-woo (left) and AbClon CEO Lee Jong-seo signed a coo...
by Lee Han-soo  |  2018-08-03 14:40
라인
Korean drugmakers rush to establish US subsidiaries
Local pharmaceutical companies are rushing to establish subsidiaries in the...
by So Jae-hyeon  |  2018-08-03 14:40
라인
Genexine, National OncoVenture to develop cervical cancer immunotherapy vaccine
Genexine said Thursday that it has signed an agreement with National OncoVe...
by Lee Han-soo  |  2018-08-02 17:33
라인
Expert advises against ‘doctor-shopping’ for uveitis treatment
A Korean expert noted the difficulties of treating uveitis in Korea, saying...
by Marian Chu  |  2018-08-02 15:37
라인
Pharmacists, convenience store owners in dispute over OTC drugs
The group of Korean pharmacists and that of convenience store owners are sl...
by So Jae-hyeon  |  2018-08-02 15:32
라인
Daewoong Bio’s dementia drug hits 3-digit sales growth
Industry watchers are paying attention to whether rising sales of generic d...
by So Jae-hyeon  |  2018-08-01 15:50
라인
GC increases in sales but loses profit in Q2
GC and its affiliates managed to increase its sales in the second quarter o...
by Lee Han-soo  |  2018-08-01 15:14
라인
Celltrion clears final Inflectra patent hurdle
Celltrion won the last patent battle for its biologic drug Inflectra (infli...
by Marian Chu  |  2018-08-01 15:12
라인
Hanmi posts ￦243.1 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded 243.1 billion won ($217....
by Lee Han-soo  |  2018-08-01 14:38
라인
‘Roche Korea’s Alecensa effective against central nervous system disease risk’
Roche Korea’s lung cancer therapy Alecensa (alectinib) proved itself to sta...
by Marian Chu  |  2018-07-31 17:57
라인
Sales of osteoporosis drugs falter, combo therapies survive
The osteoporosis treatment market is stagnating with sales of major product...
by So Jae-hyeon  |  2018-07-31 15:37
라인
Eli Lilly Korea gets reimbursement for psoriasis treatment Taltz
The Korean branch of Eli Lilly and Company said Tuesday that it gained reim...
by Marian Chu  |  2018-07-31 14:03
라인
SillaJen, Medytox one step closer to entering China
Korean biotech firms SillaJen and Medytox said they have almost completed p...
by So Jae-hyeon  |  2018-07-31 13:09
라인
Medpacto to collaborate on immunotherapy with big pharma companies
Medpacto, a subsidiary of Theragen Etex, is increasing its presence in the ...
by Lee Han-soo  |  2018-07-30 15:20
라인
[News scene] Why did pharmacists take to street in hottest weather?
Despite the hot weather with daytime highs exceeding 37 degrees Celsius acr...
by So Jae-hyeon  |  2018-07-30 14:34
라인
Pfizer gets additional indication for kidney cancer drug Sutent
Pfizer Korea said Friday it got an additional indication for its renal cell...
by Marian Chu  |  2018-07-27 18:16
라인
ABL Bio, I-Mab to cooperate on bispecific antibodies
ABL Bio said Thursday that it has signed a strategic agreement with I-Mab B...
by Lee Han-soo  |  2018-07-27 18:15
라인
iCure unveils clinical trial result for dementia patch treatment
iCure Pharmaceutical said Thursday that it has presented the phase 1 clinic...
by Lee Han-soo  |  2018-07-27 14:30
라인
CJ releases combo drug for dyslipidemia, diabetes
CJ Healthcare said Thursday that it would start marketing Atomet SR Tab., a...
by Lee Han-soo  |  2018-07-26 17:00
-12345678910-
Lawmaker bashes MFDS for loose inspectionLawmaker bashes MFDS for loose inspection
여백
Most viewed
여백
Opinion
[Column] Pyongyang summit prelude for inter-Korean health community
[Column] Pyongyang summit prelude for inter-Korean health community
[Column] What makes telemedicine controversial?
[Column] What makes telemedicine controversial?
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
여백
Back to Top